i18h
All the 'new evidence' questioning killer nurse Lucy Letby's guilt
Letby lost two attempts in 2024 to challenge her convictions at the Court of Appeal. The Crown Prosecution Service previously ...
PharmiWeb1d
CHMP recommends subcutaneous RYBREVANT® (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...
Healio4d
FDA approves third Actemra biosimilar; second available in intravenous, subcutaneous forms
The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.
News and Tribune4d
Floyd County Library launches teen STEM program
As the world becomes more reliant on new technology, the handy gadgets that make our lives easier are now commonplace.
PipelineReview.com4d
U.S. FDA approves Celltrion’s AVTOZMA® (tocilizumab-anoh), a biosimilar to ACTEMRA®
JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...
The American Journal of Managed Care5d
FDA-Approved IV Iron Formulations
Panelists discuss how modern FDA-approved intravenous iron formulations, including ferric carboxymaltose, ferumoxytol, and ...
The American Journal of Managed Care5d
Oral vs IV Iron in Clinical Practice
Panelists discuss how oral iron therapy, although convenient and cost-effective, has significant limitations, including ...
Weakness, trouble in movement, repeated injections: Recovered patients talk about theit brush with GBS
Although the disease has left him shaken and he still experiences some weakness, Pawar is now back home with his family and is trying to get back to his normal life.